Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Prognostic significance of pulmonary function tests in dyskeratosis congenita, a telomere biology disorder.

Giri N, Ravichandran S, Wang Y, Gadalla SM, Alter BP, Fontana J, Savage SA.

ERJ Open Res. 2019 Nov 15;5(4). pii: 00209-2019. doi: 10.1183/23120541.00209-2019. eCollection 2019 Oct.

2.

Genomic and Proteomic Characterizations of Sfin-1, a Novel Lytic Phage Infecting Multidrug-Resistant Shigella spp. and Escherichia coli C.

Ahamed ST, Roy B, Basu U, Dutta S, Ghosh AN, Bandyopadhyay B, Giri N.

Front Microbiol. 2019 Aug 22;10:1876. doi: 10.3389/fmicb.2019.01876. eCollection 2019.

3.

Genotype-phenotype associations in Fanconi anemia: A literature review.

Fiesco-Roa MO, Giri N, McReynolds LJ, Best AF, Alter BP.

Blood Rev. 2019 Sep;37:100589. doi: 10.1016/j.blre.2019.100589. Epub 2019 Jul 16. Review.

PMID:
31351673
4.

Dendrimer Based Nanoarchitectures in Diabetes Management: An Overview.

Mishra V, Yadav N, Saraogi GK, Tambuwala MM, Giri N.

Curr Pharm Des. 2019;25(23):2569-2583. doi: 10.2174/1381612825666190716125332.

PMID:
31333099
5.

Spectroscopy and DFT Calculations of Flavo-Diiron Nitric Oxide Reductase Identify Bridging Structures of NO-Coordinated Diiron Intermediates.

Weitz AC, Giri N, Frederick RE, Kurtz DM Jr, Bominaar EL, Hendrich MP.

ACS Catal. 2018 Dec 7;8(12):11704-11715. doi: 10.1021/acscatal.8b03051. Epub 2018 Nov 1.

PMID:
31263628
6.

Interprofessional Perceptions and Attitudes Among Pharmacy and Family Nurse Practitioner Students.

Vinluan CM, Verdell A, Ibarra C, Giri N, Thai D.

J Pharm Pract. 2019 Apr 28:897190019840100. doi: 10.1177/0897190019840100. [Epub ahead of print]

PMID:
31030602
7.

Bilayer Tablet Based Chronotherapeutics in the Management of Nocturnal Asthma: An Overview.

Thakur S, Singh B, Mishra V, Yadav N, Giri N, Sharma P, Saini A, Garg LK.

Recent Pat Drug Deliv Formul. 2019;13(2):74-82. doi: 10.2174/1872211313666190227204127.

PMID:
30827275
8.

Multimodal Chemical Imaging for Linking Adhesion with Local Chemistry in Agrochemical Multicomponent Polymeric Coatings.

Pawlicki AA, Borodinov N, Giri N, Moore S, Brown C, Belianinov A, Ievlev AV, Ovchinnikova OS.

Anal Chem. 2019 Feb 19;91(4):2791-2796. doi: 10.1021/acs.analchem.8b04607. Epub 2019 Feb 6.

PMID:
30672686
9.

Spin glass like transition and the exchange bias effect in Co3O4 nanoparticles anchored onto graphene sheets.

Sarkar S, Mondal A, Giri N, Ray R.

Phys Chem Chem Phys. 2018 Dec 19;21(1):260-267. doi: 10.1039/c8cp06659k.

PMID:
30519700
10.

Understanding the evolving phenotype of vascular complications in telomere biology disorders.

Higgs C, Crow YJ, Adams DM, Chang E, Hayes D Jr, Herbig U, Huang JN, Himes R, Jajoo K, Johnson FB, Reynolds SD, Yonekawa Y, Armanios M, Boulad F, DiNardo CD, Dufour C, Goldman FD, Khan S, Kratz C, Myers KC, Raghu G, Alter BP, Aubert G, Bhala S, Cowen EW, Dror Y, El-Youssef M, Friedman B, Giri N, Helms Guba L, Khincha PP, Lin TF, Longhurst H, McReynolds LJ, Nelson A, Olson T, Pariser A, Perona R, Sasa G, Schratz K, Simonetto DA, Townsley D, Walsh M, Stevens K, Agarwal S, Bertuch AA, Savage SA; Clinical Care Consortium for Telomere-associated Ailments (CCCTAA).

Angiogenesis. 2019 Feb;22(1):95-102. doi: 10.1007/s10456-018-9640-7. Epub 2018 Aug 25.

PMID:
30168024
11.

Serum alpha fetoprotein levels in Fanconi anaemia.

Alter BP, Giri N.

Br J Haematol. 2019 Mar;184(6):1074-1076. doi: 10.1111/bjh.15517. Epub 2018 Aug 20. No abstract available.

PMID:
30125993
12.

Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Khincha PP, Bertuch AA, Gadalla SM, Giri N, Alter BP, Savage SA.

Blood Adv. 2018 Jun 12;2(11):1243-1249. doi: 10.1182/bloodadvances.2018016964.

13.

Complex phenotype of dyskeratosis congenita and mood dysregulation with novel homozygous RTEL1 and TPH1 variants.

Ungar RA, Giri N, Pao M, Khincha PP, Zhou W, Alter BP, Savage SA.

Am J Med Genet A. 2018 Jun;176(6):1432-1437. doi: 10.1002/ajmg.a.38706. Epub 2018 Apr 25.

14.

Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers.

Yu HA, Ahn MJ, Cho BC, Gerber DE, Natale RB, Socinski MA, Giri N, Quinn S, Sbar E, Zhang H, Giaccone G.

Lung Cancer. 2017 Oct;112:195-199. doi: 10.1016/j.lungcan.2017.08.017. Epub 2017 Aug 23.

PMID:
29191595
15.

Evaluation of the effect of new formulation, food, or a proton pump inhibitor on the relative bioavailability of the smoothened inhibitor glasdegib (PF-04449913) in healthy volunteers.

Giri N, Lam LH, LaBadie RR, Krzyzaniak JF, Jiang H, Hee B, Liang Y, Shaik MN.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1249-1260. doi: 10.1007/s00280-017-3472-9. Epub 2017 Oct 30.

PMID:
29086063
16.

Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.

Alter BP, Giri N, Savage SA, Rosenberg PS.

Haematologica. 2018 Jan;103(1):30-39. doi: 10.3324/haematol.2017.178111. Epub 2017 Oct 19.

17.

Beyond the triad: Inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita.

Ward SC, Savage SA, Giri N, Alter BP, Rosenberg PS, Pichard DC, Cowen EW.

J Am Acad Dermatol. 2018 Apr;78(4):804-806. doi: 10.1016/j.jaad.2017.10.017. Epub 2017 Oct 16. No abstract available.

18.

Progressive reticulate skin pigmentation and anonychia in a patient with bone marrow failure.

Ward SC, Savage SA, Giri N, Alter BP, Cowen EW.

J Am Acad Dermatol. 2017 Dec;77(6):1194-1198. doi: 10.1016/j.jaad.2017.07.018. Epub 2017 Oct 21.

19.

Pregnancies in patients with inherited bone marrow failure syndromes in the NCI cohort.

Giri N, Stratton P, Savage SA, Alter BP.

Blood. 2017 Oct 5;130(14):1674-1676. doi: 10.1182/blood-2017-08-802991. Epub 2017 Aug 24. No abstract available.

20.

Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives.

Khincha PP, Dagnall CL, Hicks B, Jones K, Aviv A, Kimura M, Katki H, Aubert G, Giri N, Alter BP, Savage SA, Gadalla SM.

Int J Mol Sci. 2017 Aug 13;18(8). pii: E1765. doi: 10.3390/ijms18081765.

21.

Pregnancy outcomes in mothers of offspring with inherited bone marrow failure syndromes.

Giri N, Reed HD, Stratton P, Savage SA, Alter BP.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26757. Epub 2017 Aug 12.

PMID:
28801981
22.

Spectroscopy and DFT Calculations of a Flavo-diiron Enzyme Implicate New Diiron Site Structures.

Weitz AC, Giri N, Caranto JD, Kurtz DM Jr, Bominaar EL, Hendrich MP.

J Am Chem Soc. 2017 Aug 30;139(34):12009-12019. doi: 10.1021/jacs.7b06546. Epub 2017 Aug 16.

23.

Phase 1 study to investigate the pharmacokinetic properties of dacomitinib in healthy adult Chinese subjects genotyped for CYP2D6.

Chen X, Jiang J, Giri N, Hu P.

Xenobiotica. 2018 May;48(5):459-466. doi: 10.1080/00498254.2017.1342881. Epub 2017 Aug 18.

PMID:
28648122
24.

Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers.

Chen H, Giri NC, Zhang R, Yamane K, Zhang Y, Maroney M, Costa M.

J Biol Chem. 2017 Jun 23;292(25):10743. doi: 10.1074/jbc.A109.058503. No abstract available.

25.

Bone mineral density in patients with inherited bone marrow failure syndromes.

Shankar RK, Giri N, Lodish MB, Sinaii N, Reynolds JC, Savage SA, Stratakis CA, Alter BP.

Pediatr Res. 2017 Sep;82(3):458-464. doi: 10.1038/pr.2017.117. Epub 2017 May 31.

26.

Service user and care giver involvement in mental health system strengthening in Nepal: a qualitative study on barriers and facilitating factors.

Gurung D, Upadhyaya N, Magar J, Giri NP, Hanlon C, Jordans MJD.

Int J Ment Health Syst. 2017 Apr 19;11:30. doi: 10.1186/s13033-017-0139-1. eCollection 2017.

27.

Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042).

Kim DW, Garon EB, Jatoi A, Keefe DM, Lacouture ME, Sonis S, Gernhardt D, Wang T, Giri N, Doherty JP, Nadanaciva S, O'Connell J, Sbar E, Cho BC.

Lung Cancer. 2017 Apr;106:76-82. doi: 10.1016/j.lungcan.2017.01.021. Epub 2017 Feb 1.

28.

Novel and known ribosomal causes of Diamond-Blackfan anaemia identified through comprehensive genomic characterisation.

Mirabello L, Khincha PP, Ellis SR, Giri N, Brodie S, Chandrasekharappa SC, Donovan FX, Zhou W, Hicks BD, Boland JF, Yeager M, Jones K, Zhu B, Wang M, Alter BP, Savage SA.

J Med Genet. 2017 Jun;54(6):417-425. doi: 10.1136/jmedgenet-2016-104346. Epub 2017 Mar 9.

PMID:
28280134
29.

Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders.

Khincha PP, Bertuch AA, Agarwal S, Townsley DM, Young NS, Keel S, Shimamura A, Boulad F, Simoneau T, Justino H, Kuo C, Artandi S, McCaslin C, Cox DW, Chaffee S, Collins BF, Giri N, Alter BP, Raghu G, Savage SA.

Eur Respir J. 2017 Jan 25;49(1). pii: 1601640. doi: 10.1183/13993003.01640-2016. Print 2017 Jan. No abstract available.

30.

Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Xu J, Khincha PP, Giri N, Alter BP, Savage SA, Wong JM.

Am J Hematol. 2016 Dec;91(12):1215-1220. doi: 10.1002/ajh.24545. Epub 2016 Nov 4.

31.

Otologic manifestations of Fanconi anemia and other inherited bone marrow failure syndromes.

Kalejaiye A, Giri N, Brewer CC, Zalewski CK, King KA, Adams CD, Rosenberg PS, Kim HJ, Alter BP.

Pediatr Blood Cancer. 2016 Dec;63(12):2139-2145. doi: 10.1002/pbc.26155. Epub 2016 Jul 18.

PMID:
27428025
32.

A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors.

Calvo E, Soria JC, Ma WW, Wang T, Bahleda R, Tolcher AW, Gernhardt D, O'Connell J, Millham R, Giri N, Wick MJ, Adjei AA, Hidalgo M.

Clin Cancer Res. 2017 Mar 1;23(5):1177-1185. doi: 10.1158/1078-0432.CCR-15-2301. Epub 2016 Oct 12.

33.

The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita.

Gadalla SM, Khincha PP, Katki HA, Giri N, Wong JY, Spellman S, Yanovski JA, Han JC, De Vivo I, Alter BP, Savage SA.

Mol Genet Genomic Med. 2016 Mar 20;4(4):475-9. doi: 10.1002/mgg3.220. eCollection 2016 Jul.

34.

A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer.

Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Doherty JP, Giri N, Nadanaciva S, O'Connell J, Sbar E, Piperdi B, Garon EB.

Ann Oncol. 2016 Sep;27(9):1712-8. doi: 10.1093/annonc/mdw227. Epub 2016 Jun 10.

35.

Research participant interest in primary, secondary, and incidental genomic findings.

Loud JT, Bremer RC, Mai PL, Peters JA, Giri N, Stewart DR, Greene MH, Alter BP, Savage SA.

Genet Med. 2016 Dec;18(12):1218-1225. doi: 10.1038/gim.2016.36. Epub 2016 Apr 21.

36.

Influence of microwaves on the leaching kinetics of uraninite from a low grade ore in dilute sulfuric acid.

Madakkaruppan V, Pius A, T S, Giri N, Sarbajna C.

J Hazard Mater. 2016 Aug 5;313:9-17. doi: 10.1016/j.jhazmat.2016.03.050. Epub 2016 Mar 19.

PMID:
27045621
37.

Thinking of VACTERL-H? Rule out Fanconi Anemia according to PHENOS.

Alter BP, Giri N.

Am J Med Genet A. 2016 Jun;170(6):1520-4. doi: 10.1002/ajmg.a.37637. Epub 2016 Mar 30.

PMID:
27028275
38.

Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up.

Burris AM, Ballew BJ, Kentosh JB, Turner CE, Norton SA; NCI DCEG Cancer Genomics Research Laboratory; NCI DCEG Cancer Sequencing Working Group, Giri N, Alter BP, Nellan A, Gamper C, Hartman KR, Savage SA.

Pediatr Neurol. 2016 Mar;56:62-68.e1. doi: 10.1016/j.pediatrneurol.2015.12.005. Epub 2015 Dec 19.

39.

Novel FANCI mutations in Fanconi anemia with VACTERL association.

Savage SA, Ballew BJ, Giri N; NCI DCEG Cancer Genomics Research Laboratory, Chandrasekharappa SC, Ameziane N, de Winter J, Alter BP; NCI DCEG Cancer Sequencing Working Group.

Am J Med Genet A. 2016 Feb;170A(2):386-391. doi: 10.1002/ajmg.a.37461. Epub 2015 Nov 21.

PMID:
26590883
40.

Liquids with permanent porosity.

Giri N, Del Pópolo MG, Melaugh G, Greenaway RL, Rätzke K, Koschine T, Pison L, Gomes MF, Cooper AI, James SL.

Nature. 2015 Nov 12;527(7577):216-20. doi: 10.1038/nature16072.

PMID:
26560299
41.

Pituitary abnormalities in patients with Fanconi anaemia.

Kanakatti Shankar R, Giri N, Lodish MB, Butman JA, Patronas NJ, Sinaii N, Keil M, Alter BP, Stratakis CA.

Clin Endocrinol (Oxf). 2016 Feb;84(2):307-309. doi: 10.1111/cen.12883. Epub 2015 Sep 22. No abstract available.

PMID:
26300308
42.

A cascade computer model for mocrobicide diffusivity from mucoadhesive formulations.

Lee Y, Khemka A, Acharya G, Giri N, Lee CH.

BMC Bioinformatics. 2015 Aug 19;16:263. doi: 10.1186/s12859-015-0684-z.

43.

Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.

Giri N, Masters JC, Plotka A, Liang Y, Boutros T, Pardo P, O'Connell J, Bello C.

Invest New Drugs. 2015 Aug;33(4):931-41. doi: 10.1007/s10637-015-0256-0. Epub 2015 Jun 6.

PMID:
26048096
44.

Immune status of patients with inherited bone marrow failure syndromes.

Giri N, Alter BP, Penrose K, Falk RT, Pan Y, Savage SA, Williams M, Kemp TJ, Pinto LA.

Am J Hematol. 2015 Aug;90(8):702-8. doi: 10.1002/ajh.24046. Epub 2015 May 28.

45.

Synthesis by extrusion: continuous, large-scale preparation of MOFs using little or no solvent.

Crawford D, Casaban J, Haydon R, Giri N, McNally T, James SL.

Chem Sci. 2015 Mar 1;6(3):1645-1649. doi: 10.1039/c4sc03217a. Epub 2015 Jan 8.

46.

Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.

Petryk A, Kanakatti Shankar R, Giri N, Hollenberg AN, Rutter MM, Nathan B, Lodish M, Alter BP, Stratakis CA, Rose SR.

J Clin Endocrinol Metab. 2015 Mar;100(3):803-11. doi: 10.1210/jc.2014-4357. Epub 2015 Jan 9. Review.

47.

Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trial.

Park K, Cho BC, Kim DW, Ahn MJ, Lee SY, Gernhardt D, Taylor I, Campbell AK, Zhang H, Giri N, Letrent SP, O'Connell J, Heo DS.

J Thorac Oncol. 2014 Oct;9(10):1523-31. doi: 10.1097/JTO.0000000000000275.

48.

Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.

Balakumaran A, Mishra PJ, Pawelczyk E, Yoshizawa S, Sworder BJ, Cherman N, Kuznetsov SA, Bianco P, Giri N, Savage SA, Merlino G, Dumitriu B, Dunbar CE, Young NS, Alter BP, Robey PG.

Blood. 2015 Jan 29;125(5):793-802. doi: 10.1182/blood-2014-06-566810. Epub 2014 Dec 12.

49.

Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes.

Sklavos MM, Stratton P, Giri N, Alter BP, Savage SA, Pinto LA.

J Clin Endocrinol Metab. 2015 Feb;100(2):E197-203. doi: 10.1210/jc.2014-2838. Epub 2014 Nov 18.

50.

Spectroscopic and photophysical study of the demetallation of a zinc porphyrin and the aggregation of its free base in a tetraalkylphosphonium ionic liquid.

Giri NK, Banerjee A, Scott RW, Paige MF, Steer RP.

Phys Chem Chem Phys. 2014 Dec 21;16(47):26252-60. doi: 10.1039/c4cp04257c. Epub 2014 Nov 3.

PMID:
25363676

Supplemental Content

Support Center